Grainne Quinn
Directeur Technique/Scientifique/R&D chez PERRIGO COMPANY PLC
Fortune : 659 109 $ au 30/04/2024
Postes actifs de Grainne Quinn
Sociétés | Poste | Début | Fin |
---|---|---|---|
PERRIGO COMPANY PLC | Directeur Technique/Scientifique/R&D | 01/11/2015 | - |
Historique de carrière de Grainne Quinn
Anciens postes connus de Grainne Quinn
Sociétés | Poste | Début | Fin |
---|---|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Directeur Technique/Scientifique/R&D | 01/04/2009 | 01/12/2013 |
Formation de Grainne Quinn
Royal College of Surgeons | Doctorate Degree |
Statistiques
Internationale
Irlande | 4 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
PERRIGO COMPANY PLC | Health Technology |
Entreprise privées | 1 |
---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
- Bourse
- Insiders
- Grainne Quinn
- Expérience